 Elanco Animal Health Incorporated NYSE: ELAN today announced that the European Commission EC has granted approval of Elancos pending acquisition of Bayer AGs ETR: BAYN animal health business. The company continues to progress toward a mid-year closing, anticipated August 3, 2020. 